Home Carboxys Benzoic acid,5-[(3-carboxy-4-hydroxyphenyl)(3-carboxy-4-oxo-2,5-cyclohexadien-1-ylidene)methyl]-2-hydroxy-, triammonium salt

Benzoic acid,5-[(3-carboxy-4-hydroxyphenyl)(3-carboxy-4-oxo-2,5-cyclohexadien-1-ylidene)methyl]-2-hydroxy-, triammonium salt

CAS No.:
569-58-4
Catalog Number:
AG00ILH4
Molecular Formula:
Molecular Weight:
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5g
In Stock USA
United States
$33
- +
25g
In Stock USA
United States
$40
- +
100g
In Stock USA
United States
$68
- +
250g
In Stock USA
United States
$123
- +
Product Description
Catalog Number:
AG00ILH4
Chemical Name:
Benzoic acid,5-[(3-carboxy-4-hydroxyphenyl)(3-carboxy-4-oxo-2,5-cyclohexadien-1-ylidene)methyl]-2-hydroxy-, triammonium salt
CAS Number:
569-58-4
MDL Number:
MFCD00040925
IUPAC Name:
azane;5-[(3-carboxy-4-hydroxyphenyl)-(3-carboxy-4-oxocyclohexa-2,5-dien-1-ylidene)methyl]-2-hydroxybenzoic acid
InChI:
InChI=1S/C22H14O9.3H3N/c23-16-4-1-10(7-13(16)20(26)27)19(11-2-5-17(24)14(8-11)21(28)29)12-3-6-18(25)15(9-12)22(30)31;;;/h1-9,23-24H,(H,26,27)(H,28,29)(H,30,31);3*1H3
InChI Key:
AIPNSHNRCQOTRI-UHFFFAOYSA-N
EC Number:
209-319-1
Properties
Complexity:
841  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
4  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
473.143g/mol
Formal Charge:
0
Heavy Atom Count:
34  
Hydrogen Bond Acceptor Count:
12  
Hydrogen Bond Donor Count:
8  
Isotope Atom Count:
0
Molecular Weight:
473.438g/mol
Monoisotopic Mass:
473.143g/mol
Rotatable Bond Count:
5  
Topological Polar Surface Area:
172A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Literature
Title Journal
The quinone methide aurin is a heat shock response inducer that causes proteotoxic stress and Noxa-dependent apoptosis in malignant melanoma cells. The Journal of biological chemistry 20150116
Aurintricarboxylic acid modulates the affinity of hepatitis C virus NS3 helicase for both nucleic acid and ATP. Biochemistry 20130910
Selective inhibition of the membrane attack complex of complement by low molecular weight components of the aurin tricarboxylic acid synthetic complex. Neurobiology of aging 20121001
Trimethylaurintricarboxylic acid inhibits human DNA methyltransferase 1: insights from enzymatic and molecular modeling studies. Journal of molecular modeling 20120401
Anomalous inhibition of c-Met by the kinesin inhibitor aurintricarboxylic acid. International journal of cancer 20120301
Quantization of bovine serum albumin by fluorescence enhancement effects and corresponding binding of macrocyclic host-protein assembly. Journal of photochemistry and photobiology. B, Biology 20120105
Molecular modeling of inhibitors of human DNA methyltransferase with a crystal structure: discovery of a novel DNMT1 inhibitor. Advances in protein chemistry and structural biology 20120101
Mechanisms of xenogeneic baboon platelet aggregation and phagocytosis by porcine liver sinusoidal endothelial cells. PloS one 20120101
Aurintricarboxylic acid promotes the conversion of naive CD4+CD25- T cells into Foxp3-expressing regulatory T cells. International immunology 20110901
Aurintricarboxylic acid inhibits the nuclear factor-κB-dependent expression of intercellular cell adhesion molecule-1 and endothelial cell selectin on activated human endothelial cells. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20110301
Investigations on the interactions of aurintricarboxylic acid with bovine serum albumin: Steady state/time resolved spectroscopic and docking studies. Journal of photochemistry and photobiology. B, Biology 20110110
Cosalane and its analogues: a unique class of anti-HIV agents. Mini reviews in medicinal chemistry 20100901
Lack of efficacy of aurintricarboxylic acid and ethacrynic acid against vaccinia virus respiratory infections in mice. Antiviral chemistry & chemotherapy 20100414
Inhibition of enterovirus 71 replication and the viral 3D polymerase by aurintricarboxylic acid. The Journal of antimicrobial chemotherapy 20100401
N-acetylcysteine impairs survival of luteal cells through mitochondrial dysfunction. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20100401
Interaction of aurintricarboxylic acid (ATA) with four nucleic acid binding proteins DNase I, RNase A, reverse transcriptase and Taq polymerase. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20091201
Characterization of aurintricarboxylic acid as a potent hepatitis C virus replicase inhibitor. Antiviral chemistry & chemotherapy 20090925
Single-strand DNA translation initiation step analyzed by Isothermal Titration Calorimetry. Biochemical and biophysical research communications 20090731
Discovery of selective glucocorticoid receptor modulators by multiplexed reporter screening. Proceedings of the National Academy of Sciences of the United States of America 20090324
Aurintricarboxylic acid inhibits influenza virus neuraminidase. Antiviral research 20090201
Citrate-mediated release of aurintricarboxylic acid from a calcium alginate complex: implications for intravaginal HIV chemoprophylaxis and related applications. Pharmaceutical development and technology 20090101
Aurintricarboxylic acid is a potent inhibitor of influenza A and B virus neuraminidases. PloS one 20090101
In vitro and in vivo activity of aurintricarboxylic acid preparations against Cryptosporidium parvum. The Journal of antimicrobial chemotherapy 20081101
Selection of an effective red-pigment producing Monascus pilosus by efficient transformation with aurintricarboxylic acid. Bioscience, biotechnology, and biochemistry 20081101
Posttreatment with the Ca(2+)-Mg(2+)-dependent endonuclease inhibitor aurintricarboxylic acid abolishes genotoxic agent-induced nuclear condensation and DNA fragmentation and decreases death of astrocytes. Journal of neuroscience research 20081001
A new binding assay of von Willebrand factor and glycoprotein Ib using solid-phase biotinylated platelets. Journal of pharmacological sciences 20081001
Apoptosis of mesenchymal cells during the pseudoglandular stage of lung development affects branching morphogenesis. Experimental lung research 20081001
Aurintricarboxylic acid upregulates the thrombomodulin expression of endothelial cells and peripheral blood monocytes. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20080901
Platelet GPIb complex as a target for anti-thrombotic drug development. Thrombosis and haemostasis 20080301
Gene expression-based screening for inhibitors of PDGFR signaling. Genome biology 20080101
Aurintricarboxylic acid inhibits endothelial activation, complement activation, and von Willebrand factor secretion in vitro and attenuates hyperacute rejection in an ex vivo model of pig-to-human pulmonary xenotransplantation. Xenotransplantation 20080101
Apoptosis as a therapeutic target in heart failure. American journal of physiology. Heart and circulatory physiology 20070901
A new evidence for DNA nicking property of amyloid beta-peptide (1-42): relevance to Alzheimer's disease. Archives of biochemistry and biophysics 20070715
Biodegradable magnesium scaffolds: Part 1: appropriate inflammatory response. Journal of biomedical materials research. Part A 20070601
Aurintricarboxylic acid inhibits protein synthesis independent, sanguinarine-induced apoptosis and oncosis. Toxicologic pathology 20070201
Cortisol promotes survival and regeneration of axotomised retinal ganglion cells and enhances effects of aurintricarboxylic acid. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20061101
Oral gene delivery: design of polymeric carrier systems shielding toward intestinal enzymatic attack. Biopolymers 20061101
Influence of the SCGE protocol on the amount of basal DNA damage detected in the Mediterranean mussel, Mytilus galloprovincialis. Environmental and molecular mutagenesis 20061001
Biological evaluation, chelation, and molecular modeling studies of novel metal-chelating inhibitors of NF-kappaB-DNA binding: structure activity relationships. Journal of medicinal chemistry 20060615
Post-treatment with the Ca(2+)-Mg(2+)-endonuclease inhibitor aurintricarboxylic acid prevents peroxynitrite-induced DNA damage and death of murine astrocytes. Biochemical and biophysical research communications 20060609
Fusion and differentiation of murine C2C12 skeletal muscle cells that express Trichinella spiralis p43 protein. Experimental parasitology 20060201
Paradoxical effects of aurintricarboxylic acid and RG-13577: acute thrombosis and in-stent stenosis in a passive-coated stent. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists 20060201
Dendritic supermolecules--towards controllable nanomaterials. Chemical communications (Cambridge, England) 20060107
Salt is necessary for nucleosomal DNA fragmentation induced by caspase. Biotechnology letters 20051201
Barriers to productive transfection of trabecular meshwork cells. Molecular vision 20051026
Structural analysis of inhibition mechanisms of aurintricarboxylic acid on SARS-CoV polymerase and other proteins. Computational biology and chemistry 20050601
Use of the nuclease inhibitor aurintricarboxylic acid (ATA) for improved non-viral intratumoral in vivo gene transfer by jet-injection. The journal of gene medicine 20050401
Differential activation of heme oxygenase-1 by chalcones and rosolic acid in endothelial cells. The Journal of pharmacology and experimental therapeutics 20050201
p66ShcA and ageing: modulation by longevity-promoting agent aurintricarboxylic acid. Mechanisms of ageing and development 20050201
Coordinate involvement of cysteine protease and nuclease in the executive phase of plant apoptosis. FEBS letters 20041217
Induction of apoptosis by benzamide and its inhibition by aurin tricarboxylic acid (ATA) in Chinese hamster V79 cells. Mutation research 20041004
Aurintricarboxylic acid translocates across the plasma membrane, inhibits protein tyrosine phosphatase and prevents apoptosis in PC12 cells. Molecules and cells 20040831
Potent and selective inhibition of SARS coronavirus replication by aurintricarboxylic acid. Biochemical and biophysical research communications 20040806
Novel shift of Jak/Stat signalling characterizes the protective effect of aurintricarboxylic acid (ATA) from tumor necrosis factor-alpha toxicity in human B lymphocytes. International journal of immunopathology and pharmacology 20040101
Enhanced systemic transgene expression after nonviral salivary gland transfection using a novel endonuclease inhibitor/DNA formulation. Gene therapy 20031201
Mitigation of tumor necrosis factor alpha cytotoxicity by aurintricarboxylic acid in human peripheral B lymphocytes. Biochemical pharmacology 20031115
Qbeta replicase discriminates between legitimate and illegitimate templates by having different mechanisms of initiation. The Journal of biological chemistry 20031107
Aurintricarboxylic acid blocks in vitro and in vivo activity of YopH, an essential virulent factor of Yersinia pestis, the agent of plague. The Journal of biological chemistry 20031024
Inhibition of myocardial apoptosis reduces infarct size and improves regional contractile dysfunction during reperfusion. Cardiovascular research 20030701
Transient reporter gene (GUS) expression in creeping bentgrass (Agrostis palustris) is affected by in vivo nucleolytic activity. Biotechnology letters 20030601
Amino acids interfere with the ERK1/2-dependent control of macroautophagy by controlling the activation of Raf-1 in human colon cancer HT-29 cells. The Journal of biological chemistry 20030509
Hyperacute lung rejection in the pig-to-human model. III. Platelet receptor inhibitors synergistically modulate complement activation and lung injury. Transplantation 20030415
[Resonance light scattering of aurintricarboxylic acid]. Guang pu xue yu guang pu fen xi = Guang pu 20030201
Enhanced transport of a novel anti-HIV agent--cosalane and its congeners across human intestinal epithelial (Caco-2) cell monolayers. International journal of pharmaceutics 20030102
Spontaneous DNA fragmentation in swim-up selected human spermatozoa during long term incubation. Journal of andrology 20030101
Non-classic characteristics define prominent DNase activities from the intestine and other tissues of Haemonchus contortus. Experimental parasitology 20030101
Inhibition of cytokine-induced JAK-STAT signalling pathways by an endonuclease inhibitor aurintricarboxylic acid. British journal of pharmacology 20021201
Polymorphisms of glycoprotein Ib affect the inhibition by aurintricarboxylic acid of the von Willebrand factor dependent platelet aggregation. Journal of molecular medicine (Berlin, Germany) 20021201
Electroporation in combination with a plasmid vector containing SV40 enhancer elements results in increased and persistent gene expression in mouse muscle. Biochemical and biophysical research communications 20021108
Aurintricarboxylic acid attenuates intimal thickening after balloon injury of the rabbit aorta. Thrombosis and haemostasis 20021001
Development of nonradioactive microtiter plate assays for nuclease activity. Analytical biochemistry 20021001
Aluminum deposition in the bone of patients with chronic renal failure--detection of aluminum accumulation without signs of aluminum toxicity in bone using acid solochrome azurine. Clinical nephrology 20021001
Aurintricarboxylic acid protects against cell death caused by lipopolysaccharide in macrophages by decreasing inducible nitric-oxide synthase induction via IkappaB kinase, extracellular signal-regulated kinase, and p38 mitogen-activated protein kinase inhibition. Molecular pharmacology 20020701
Aurintricarboxylic acid induces a distinct activation of the IGF-I receptor signaling within MDA-231 cells. Endocrinology 20020301
Modulation of apoptosis by mitochondrial uncouplers: apoptosis-delaying features despite intrinsic cytotoxicity. Biochemical pharmacology 20020201
Intestinal absorption and biodistribution of cosalane and its amino acid conjugates: novel anti-HIV agents. International journal of pharmaceutics 20020114
DNA transfection of macaque and murine respiratory tissue is greatly enhanced by use of a nuclease inhibitor. The journal of gene medicine 20020101
[RNA, unlike DNA, binds to aurintricarboxylic acid via covalent bonds: molecular-biological and spectroscopic evidence]. Ukrains'kyi biokhimichnyi zhurnal (1999 ) 20020101
Purification and characterization of a Bacillus subtilis 168 nuclease, YokF, involved in chromosomal DNA degradation and cell death caused by thermal shock treatments. The Journal of biological chemistry 20011214
Effects of fibrinogen receptor antagonist GR144053F and aurintricarboxylic acid on platelet activation and degranulation. Biochemical pharmacology 20011115
Synthesis and anti-HIV activity of cosalane analogues incorporating two dichlorodisalicylmethane pharmacophore fragments. Bioorganic & medicinal chemistry 20011101
Perforated microelectrode arrays implanted in the regenerating adult central nervous system. Experimental neurology 20010901
Activation of the insulin-like growth factor 1 signaling pathway by the antiapoptotic agents aurintricarboxylic acid and evans blue. Endocrinology 20010701
Binding of cosalane--a novel highly lipophilic anti-HIV agent--to albumin and glycoprotein. Journal of pharmaceutical sciences 20010501
Correlation of anti-HIV activity with anion spacing in a series of cosalane analogues with extended polycarboxylate pharmacophores. Journal of medicinal chemistry 20010301
Pharmacological interventions of cyanide-induced cytotoxicity and DNA damage in isolated rat thymocytes and their protective efficacy in vivo. Toxicology letters 20010203
Inhibition of RANTES/CCR1-mediated chemotaxis by cosalane and related compounds. Bioorganic & medicinal chemistry letters 20010108
Aurintricarboxylic acid decreases proliferative potential of SKOV3 and MCF7 human carcinoma cells. Anticancer research 20010101
Anti-HIV activity of a series of cosalane amino acid conjugates. Bioorganic & medicinal chemistry letters 20001120
Identification of optimal anion spacing for anti-HIV activity in a series of cosalane tetracarboxylates. Bioorganic & medicinal chemistry letters 20000918
Synthesis and anti-HIV activity of cosalane analogues incorporating nitrogen in the linker chain. Bioorganic & medicinal chemistry 20000101
N-Nitrosodimethylamine-mediated cytotoxicity in a cell line expressing P450 2E1: evidence for apoptotic cell death. Toxicology and applied pharmacology 19990601
The toxicity of 6-hydroxydopamine on PC12 and P19 cells. Brain research. Molecular brain research 19990521
Extension of the polyanionic cosalane pharmacophore as a strategy for increasing anti-HIV potency. Journal of medicinal chemistry 19990520
Synthesis of a cosalane analog with an extended polyanionic pharmacophore conferring enhanced potency as an anti-HIV agent. Bioorganic & medicinal chemistry letters 19980407
Exploration of the effects of linker chain modifications on anti-HIV activities in a series of cosalane analogues. Bioorganic & medicinal chemistry 19961001
Synthesis and biological evaluation of certain alkenyldiarylmethanes as anti-HIV-1 agents which act as non-nucleoside reverse transcriptase inhibitors. Journal of medicinal chemistry 19960802
Correlation of anti-HIV potency with lipophilicity in a series of cosalane analogs having normal alkenyl and phosphodiester chains as cholestane replacements. Journal of medicinal chemistry 19960119
Cosalane analogues with enhanced potencies as inhibitors of HIV-1 protease and integrase. Journal of medicinal chemistry 19950203
Design, synthesis, and biological evaluation of cosalane, a novel anti-HIV agent which inhibits multiple features of virus reproduction. Journal of medicinal chemistry 19940916
Inhibition of HIV-1 integration protein by aurintricarboxylic acid monomers, monomer analogs, and polymer fractions. Biochemical and biophysical research communications 19920529
[The anti-HIV activity of beta-glycyrrhizic acid]. Voprosy virusologii 19920101
Preparation and anti-HIV activities of aurintricarboxylic acid fractions and analogues: direct correlation of antiviral potency with molecular weight. Journal of medicinal chemistry 19910101
Synthesis and anti-HIV activities of low molecular weight aurintricarboxylic acid fragments and related compounds. Journal of medicinal chemistry 19910101
Aurintricarboxylic acid and Evans Blue represent two different classes of anionic compounds which selectively inhibit the cytopathogenicity of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus. Biochemical and biophysical research communications 19860414
Properties